Navigation Links
Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Date:10/14/2010

SAN DIEGO, Oct. 14 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it is offering to sell shares of its common stock in an underwritten public offering. Anadys also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. All of the shares in the offering are to be sold by Anadys. Lazard Capital Markets LLC is acting as sole book-running manager in the offering.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Anadys intends to use the net proceeds from the offering to support a Phase IIb study of ANA598, which Anadys is on track to commence early in the first quarter of 2011, as well as for general corporate purposes, including working capital.

The securities described above are being offered by Anadys pursuant to a shelf registration statement and accompanying prospectus on Form S-3 previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on April 23, 2009.  A preliminary prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's web site at http://www.sec.gov.  When available, copies of the preliminary prospectus supplement relating to these securities may also be obtained from the offices of Lazard Capital Markets LLC at 30 Rockefeller Plaza, 60th Floor, New York, NY, 10020 or via telephone at (800) 542-0970.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any s
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") ... to divest in the United States ... Discovery® Elbow System assets and Cobalt™ bone cement assets.  ... acquisition of Biomet, Inc. ("Biomet").  , ... the Bureau of Competition Staff of the U.S. Federal ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical companies ... drugs and tests, and this is translating ... that can assist them. This according to Kalorama ... said instruments such as mass spectrometry, electrophoresis ... the identification of drug targets and the ...
(Date:5/28/2015)... May 28, 2015  Maetrics ( http://maetrics.com ), a ... sector, wrapped up a successful conference, "The cost of ... industry," today in Zurich . ... and its Switzerland -based team, experts ... Medical Technology field to an exclusive local audience. The ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: ... specialty pharmaceuticals company in China, today announced financial results for ... ThirdQ uarter Highlights Revenue increased ... quarter of fiscal year 2009 Excluding an adjustment for ...
... USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino -- BOSTON, November 11, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, ...
Cached Medicine Technology:China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 2China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 3China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 4China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 5China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 6China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 7China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 8China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 9EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 2EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 3EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 4EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 5EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 6EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 7EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 8
(Date:5/28/2015)... Are policies that spell out when Medicare pays ... pain for seniors? That’s what a study published this ... to figure out, and its findings could have implications ... study, “Observation Encounters and Subsequent Nursing Facility Stays,” ... Medicare policies that distinguish between an “inpatient” hospital stay ...
(Date:5/28/2015)... 2015 The Paw Project, ... dramatic billboard intended to educate the Oregon public about ... busy intersection of Market Street and Park Avenue in ... You’re for De-clawing Cats, Raise Your Hand,” depicts a ... joint, providing a graphic and anatomically-correct representation of the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 " Trends Investing ... Biz Report, which takes a look at small, medium, and ... the host of NewsWatch and business expert, conducted the business ... guides users to where they should invest their money. , ... sound concept. But doing it and knowing how to ...
(Date:5/28/2015)... FL (PRWEB) May 28, 2015 Nidra Herbal ... incredibly gentle on the body. A non-addictive supplement, Nidra Herbal ... blend of natural ingredients will leave users with a real ... system of care , Ayurveda, which translates as the “Science ... than 5,000 years ago and is a holistic system of ...
(Date:5/28/2015)... May 28, 2015 Healthpointe is ... now be offering Echocardiography Examinations to patients with ... by renowned Qualified Medical Examiner and licensed Cardiologist, ... test is a non-invasive and cost-effective approach to ... critically ill or have undergone surgery. Also ...
Breaking Medicine News(10 mins):Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2
... to Enhance Patient Safety, Efficiency, SAN RAMON, ... global services firm that specializes in enabling,transformation of ... it has signed a $1.5 million five-year contract ... that includes 331 skilled nursing,facilities and 19 assisted ...
... 29 Sun Pharmaceutical Industries,Ltd. (Reuters: SUN.BO, Bloomberg: ... letter to Barrie Levitt, M.D., Chairman of Taro ... purported,termination of the May 18, 2007 merger agreement ... Director of Sun, said, "Taro is,not entitled to ...
... time makes ovaries lose their ability to produce estrogens ... In this stage, when menstruation cesses, there appear physical ... dryness, articulation and bone pain, headaches, insomnia, sadness, depression ... Spain, the average age for the cessation of the ...
... Winning Entries From Oncology on Canvas(SM) To Be On ... is Not a Dress,Rehearsal," "More Than a Statistic," "Why ... represented in art and narrative at an exhibit,featuring selected ... a Cancer Journey Art Competition and Exhibition. The art ...
... Stress, hormone imbalances to blame for a condition many women suffer ... ... day, women worldwide,look in the mirror, and where they used to see ... hair loss, they try,to hide it with make-up, creative hairstyles, or sometimes ...
... INDIANAPOLIS, May 29 People who favor,flip-flops as ... lower leg pain and a change in their stride, ... of the American College,of Sports Medicine (ACSM) in Indianapolis., ... with the observation,that most people appear to be wearing ...
Cached Medicine News:Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 2Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:Post-menopausal therapy to improve women's quality of life 2Health News:Art Exhibit Honors National Cancer Survivors Day 2Health News:Art Exhibit Honors National Cancer Survivors Day 3Health News:Hair Loss Is on the Rise, and Women Are Among the Hardest Hit 2Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3